IASO Biotherapeutics Completes Acquisition of MediSix Therapeutics – Adding PEBL‑Based CAR‑T Cell Therapy Platform for T‑Cell Malignancies
IASO Biotherapeutics, a Chinese cell therapy innovator, announced today that it has completed its acquisition...